New Zealand Based Nutrition Company Files a Patent on a Novel Zinc Supplement
WELLINGTON, New Zealand, Nov. 3, 2020 /PRNewswire/ --LAZU, a health and nutrition brand, based in Kapiti Coast, New Zealand has announced today, that it filed a final update to its patent application for its novel zinc ionophore supplement, LAZU Virocin.
- WELLINGTON, New Zealand, Nov. 3, 2020 /PRNewswire/ --LAZU, a health and nutrition brand, based in Kapiti Coast, New Zealand has announced today, that it filed a final update to its patent application for its novel zinc ionophore supplement, LAZU Virocin.
- However, the concentration of zinc within our cells is tightly controlled and regulated.
- To be truly effective, zinc needs help from a special transporter molecule called a 'zinc ionophore'.
- The LAZU Virocin is sold in the United States and New Zealand and is also available through the website; https://www.lazu.co.nz/product/lazu-virocin/